Navigation Links
Accera, Inc. Sponsors Alzheimer's Association's 2009 ICAD Conference
Date:2/17/2009

BROOMFIELD, Colo., Feb. 17 /PRNewswire/ -- Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system (CNS) diseases, announced today it is a SILVER level sponsor of the 2009 International Conference on Alzheimer's Disease (ICAD). The annual conference, put on by the Alzheimer's Association, is the world's leading forum on dementia research. ICAD 2009 will take place July 11-16 in Vienna, Austria.

"Alzheimer's is a progressive and fatal disease that significantly impacts millions of patients, their families and caregivers," said Steve Orndorff, Ph.D., Accera's founder and CEO. "As a company focused on CNS disorders, Accera is committed to improving the care and quality of life of Alzheimer's patients who are in need of innovative, safe, new therapeutic options. By supporting ICAD we are joining the Alzheimer's Association in their quest to advance research, care and support for AD."

In the U.S., 5.2 million people are living with AD and it has become the sixth leading cause of death. There is currently no cure for AD and there is a tremendous need for new and innovative therapies.

ICAD 2009 is expected to draw approximately 5,000 researchers, clinicians and neurologists from around the world to engage in a multidisciplinary exchange of ideas. The international sharing of research looks to advance prevention methods, treatments and a cure for AD.

About ICAD

The Alzheimer's Association International Conference on Alzheimer's Disease (ICAD) is the largest gathering of international leaders in Alzheimer research and care. At ICAD, researchers from around the world share groundbreaking information and resources on the cause, diagnosis, treatment and prevention of Alzheimer's and related disorders. As a part of the Association's research program, ICAD serves as a catalyst for generating new knowledge about dementia and fostering a vital, colle
'/>"/>

SOURCE Accera, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Accera, Inc. to Present at the 4th Annual BIO Investor Forum
2. Accera, Inc. Names William T. Poncy Vice President of Commercial Development
3. Accera, Inc. Completes $35 Million Series C Financing
4. Diageo Sponsors Medical Society of the State of New Yorks Physicians Training Program
5. SLIM Search, Inc. Sponsors Next Generation Sequencing Conference for the Biomedical Market
6. Varian Medical Systems Sponsors Special Broadcast of The Group Room(R), a Live Radio Talkshow About Cancer
7. Baxa Announces Colorado BioScience Association Sponsorship
8. Diplomat Specialty Pharmacy Sponsors National Managed Care Roundtable for Industry Executive Advisory Board
9. BioStorage Technologies Announces Platinum Sponsorship of Biorepositories 2008
10. TCN e-Systems Offers Trial Sponsors Solutions for Creating In-House Center of Excellence in Patient Recruitment
11. InVitria Sponsors Cambridge Healthtechs Optimizing Cell Culture Development Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/18/2010)... Molecular ... ... 2010 -- Celsense, Inc. announced today its launch of the first off-the-shelf ... optimize the use of Celsense’ imaging reagents but will be made available to any ...
(Date:3/17/2010)... , ,, ANN ARBOR, Mich.---In findings that took the experimenters ... their collaborators have demonstrated that light itself can twist ... the current edition of Science . , Matter ... optical lenses and polarizing 3-D movie glasses. But the ...
(Date:3/17/2010)... ... need for innovation to meet growing global needs sustainably. , ... Washington, DC (PRWEB) March 17, 2010 -- ... of benefits modern agriculture has provided to society and emphasized the importance of continued ...
(Date:3/17/2010)... NOVATO, Calif. , March 17 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today announced that Dan Maher , Senior Vice President of Product Development of ... .   , ... , , ... ...
Breaking Biology Technology:Novel Imaging Software Released by Celsense Inc. 2Novel Imaging Software Released by Celsense Inc. 3Light twists rigid structures in unexpected nanotech finding 2Light twists rigid structures in unexpected nanotech finding 3Global Food Security Depends on Modern Agriculture 2Global Food Security Depends on Modern Agriculture 3Global Food Security Depends on Modern Agriculture 4BioMarin to Present at the Barclays Capital Global Healthcare Conference 2BioMarin to Present at the Barclays Capital Global Healthcare Conference 3
... , Multiporator / Electroporator 2510 , , , , , , ... Protocol No. 4308 915.509 12/2001 , , ... , , Microorganism , ... Cell type , Bacteria, gram positive, , ...
... , , , , , , Multiporator / Electroporator 2510 , , ... , Transformation Protocol , Protocol No. ... , , , , , , ... , , Cell type , ...
... Multiporator , , , , , , , ... Protocol No. 4308 915.042 11/2001 , , , , , ... , Cell line , B16, mouse melanoma cells, ... Plasmid pEGFP-N1 (in bidistilled H 2 O), , ...
Other Biology Technology:Clostridium botulinum 2Borrelia burgdorferi 2B16 2
(Date:3/18/2010)... , Michael M. Graham, Ph.D., M.D., president, SNM, ... SNM Medical Isotope Task Force, Jeffrey P. Norenberg, Pharm.D., ... SNM Medical Isotope Task Force, , WHEN:,Immediately , ... a two-week period when cancer, heart and brain disease ...
(Date:3/18/2010)... effort to mirror the ability of biological tissues to ... the McGowan Institute for Regenerative Medicine have synthesized a ... and chemical toxins. They described the findings recently in ... to create materials that can do many things, just ...
(Date:3/18/2010)... a range of unique and highly specific monoclonal and ... which counteract bacteria, viruses or cancerous cells. This was ... which are important components of cellular signalling pathways. ... experimental studies. A further key advance is the incorporation ...
Breaking Biology News(10 mins):Multifunctional polymer neutralizes both biological and chemical weapons 2Manufacturing antibodies 2Manufacturing antibodies 3Swiss Environmental Company Taps RSA to Ensure Business Continuity in the Event of Global H1N1 Pandemic 61146 1Swiss Environmental Company Taps RSA to Ensure Business Continuity in the Event of Global H1N1 Pandemic 61146 2Swiss Environmental Company Taps RSA to Ensure Business Continuity in the Event of Global H1N1 Pandemic 61146 3NOVAVAX to Present at the Influenza Congress USA 2009 61142 1NOVAVAX to Present at the Influenza Congress USA 2009 61142 2Biotechnology Salutes Americas Veterans 3B Innovations Continue to Offer Improved Treatment and Care of Combat Troops 6171 1Biotechnology Salutes Americas Veterans 3B Innovations Continue to Offer Improved Treatment and Care of Combat Troops 6171 2
... more evidence that it's time for long-time antibiotic stalwarts ... comes to the treatment of strep throat. , The ... the bug that causes millions of sore throats in ... and aren't as effective as newer antibiotics known as ...
... perception and susceptibility to drug dependence is expressed more ... this difference coincides with the evolution of our species, ... academic institutions. Their report appears in the December issue ... gene encodes prodynorphin, an opium-like protein implicated in the ...
... Link to the project website , The ... has this year been granted to the project 'Virtual ... Research Group of the university. The awarded project utilizes ... and view microscopy specimens over the internet. , ...
Other Biology News:Penicillin, amoxicillin: Step aside for strep throat treatment 2Penicillin, amoxicillin: Step aside for strep throat treatment 3'Perception' gene tracked humanity's evolution, scientists say 2'Perception' gene tracked humanity's evolution, scientists say 3
Goat polyclonal to Lipocalin 2...
Human GCP-2 is a member of the CXC family of chemokines. It also promotes neutrophil chemotaxis and deganulation. GF063 is an 8.0 kDa protein containing 73 amino acid residues....
... By immunoblotting the antibody reacts against the ... free MMP-2 or MMP-2 bound to TIMP-2. ... solution Solution in 0.01 M phosphate ... and 15 mM sodium azide. synthetic peptide ...
human Exodus-2 Research Focus: cytokine/growth factor Storage Temperature: -20C Shipping Temperature: 4C...
Biology Products: